IRIDEX CORP

IRIDEX Corporation is an ophthalmic medical technology company that develops and sells products and procedures to treat sight-threatening eye conditions like glaucoma and retinal diseases. The company's proprietary MicroPulse® Technology and Endpoint Management™ Technology are used for treating glaucoma and retina disorders. These technologies are available as optional treatment modes in select laser consoles, alongside the standard continuous-wave ("CW") treatment mode. MicroPulse technology uses short, microsecond-long laser pulses, allowing tissue to cool between pulses for finer control of thermal elevation and minimized tissue damage. Endpoint Management technology uses a delivery algorithm to adjust laser energy. Both MicroPulse and Endpoint Management technologies have shown clinical effectiveness with a safer profile compared to standard high-energy CW laser for treating retinal diseases and glaucoma. IRIDEX's products include laser consoles, delivery devices, and consumable probes. The laser consoles are categorized into three product lines: Glaucoma, which features the Cyclo G6® laser system with MicroPulse technology; Medical Retina, which includes the portable IQ 532® and IQ 577® laser systems with MicroPulse technology, and the Pattern Scanning Laser ("PASCAL") System with Endpoint Management technology and MicroPulse technology; and Surgical Retina, which offers the OcuLight® TX and OcuLight® SLx (with MicroPulse technology) laser photocoagulation systems. These systems are often used in vitrectomy procedures for conditions such as proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.